Transoesophageal Echocardiography And Cardioversion: Feasibility of A Combined Approach in Clinical Practice
Background
Atrial fibrillation, the most common clinically important arrhythmia, is often treated by external cardioversion preceeded by transoesophageal echo (TOE) which are usually performed as separate procedures. We performed TOE and cardioversion as a combined procedure to evaluate its safety and feasibility.
Method
173 patients were referred for a combined procedure; 154 underwent a combined TOE and cardioversion. We evaluated the safety and the duration of hospital stay in this group of patients. A cost analysis was performed comparing 32 patients (Group 1) who had a combined procedure in the first 6 months, with 18 patients who had two separate procedures (Group 2) in the 6 months preceeding this.
Results
Analysis of 154 patients who underwent the combined procedure demonstrated a median time from admission to discharge of 9
h with a mean procedure time of 36min. No significant technical problems were identified with the combined procedure as a single sedation. Total admission time, TOE to discharge time (p<0.0001) and procedural costs were lower in Group 1.
Conclusion
Combined TOE and cardioversion is an effective and safe procedure that permits a patient to have a single sedation with a short hospital stay with decreased health costs.
Keywords: Tranoesophageal echocardiography, Cardioversion, Atrial fibrillation, Cost benefit
To access this article, please choose from the options below
PII: S1443-9506(07)01075-X
doi:10.1016/j.hlc.2007.10.010
© 2007 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of Australia and New Zealand. Published by Elsevier Inc. All rights reserved.
